Brainomix and Boehringer Ingelheim Advance Strategic Partnership in Pulmonary Fibrosis
Dr. Michalis Papadakis, CEO and Co-Founder of Brainomix said: “We are excited to expand our strategic partnership with Boehringer Ingelheim, a recognized leader and innovator in this field, with whom we share a firm commitment to improving outcomes for people living with pulmonary fibrosis.
May 12, 2026